newsfilter
← Latest News
GlobeNewswire·

Magenta Therapeutics to Present Data at the 2022 American Society of Hematology (ASH) Annual Meeting

– Oral presentation of MGTA-117 Phase 1/2 dose escalation clinical trial abstract, with additional clinical data supporting proof-of-mechanism – – Poster presentation of data from a MGTA-117 non-human primate study that